ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2024
Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 7 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 7 institutions in 3 countries.
Kate GersekowskiPopulation Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0003-4359-3582
Renhua NaPopulation Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-9830-8462
Kathryn AlsopPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-4107-3041
Rachel DelahuntyPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0002-1859-9651
Ellen L GoodeDivision of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-9094-8326
Julie M CunninghamDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-8159-3025
Stacey J WinhamDivision of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-8492-9102
Paul D P PharoahDepartment of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, California.ORCID 0000-0001-8494-732X
Honglin SongDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-5076-7371
Penelope M WebbPopulation Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0003-0733-5930
Mayo Clinic in Florida · USPeter MacCallum Cancer Centre · AUQIMR Berghofer Medical Research Institute · AUCedars-Sinai Medical Center · USMayo Clinic · USQueensland Health · AUUniversity of Cambridge · GB
Funding
Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI ELLEN L. GOODE · 2009 to 2026
$37.0M
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and RiskR01CA248288 · NCI · MAYO CLINIC ROCHESTER · PI Stacey J Winham · 2021 to 2026
$4.8M
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer EtiologyR01CA122443 · NCI · MAYO CLINIC ROCHESTER · PI GOODE, ELLEN L. · 2007 to 2012
$2.7M
Australian Government (Federal Government)Cancer Australia 509303Cancer Council NSW (Cancer Council New South Wales) 182Cancer Council NSW (Cancer Council New South Wales) 191Cancer Council NSW (Cancer Council New South Wales) 211Cancer Council Queensland (CCQ) 182Cancer Council Queensland (CCQ) 191Cancer Council Queensland (CCQ) 211Cancer Council South Australia (Cancer Council SA) 182Cancer Council South Australia (Cancer Council SA) 191Cancer Council South Australia (Cancer Council SA) 211Cancer Council Tasmania (Cancer Council of Tasmania) 182Cancer Council Tasmania (Cancer Council of Tasmania) 191Cancer Council Tasmania (Cancer Council of Tasmania) 211Cancer Council Victoria 182Cancer Council Victoria 191Cancer Council Victoria 211Cancer Council Western Australia (Cancer Council WA) 182Cancer Council Western Australia (Cancer Council WA) 191Cancer Council Western Australia (Cancer Council WA) 211Cancer Research UK (CRUK) C490/A10119Cancer Research UK (CRUK) C490/A10124Fraternal Order of Eagles (FOE)Fred C. and Katherine B. Andersen Foundation (Fred C and Katherine B Andersen Foundation)Mayo Foundation for Medical Education and Research (MFMER)Minnesota Ovarian Cancer Alliance (MOCA)National Health and Medical Research Council (NHMRC) 199600National Health and Medical Research Council (NHMRC) 400281National Health and Medical Research Council (NHMRC) 400413National Health and Medical Research Council (NHMRC) APP1025142National Health and Medical Research Council (NHMRC) APP1120431National Health and Medical Research Council (NHMRC) GNT1073898National Health and Medical Research Council (NHMRC) GNT1173346National Institutes of Health (NIH) P30-CA15083National Institutes of Health (NIH) P50-CA136393National Institutes of Health (NIH) R01-CA122443NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA122443NCI NIH HHS R01 CA248288NIHR BioResource (National Institute for Health Research Bioresource)Ovarian Cancer AustraliaOvarian Cancer Research Fund (OCRF)Peter MacCallum Foundation (Peter Mac)U.S. Army (USA) DAMD17-01-1-0729U.S. Department of Defense (DOD) W81XWH-08-1-0684U.S. Department of Defense (DOD) W81XWH-08-1-0685
6 · The paper itself
Abstract
backgroundWomen with an inherited pathogenic variant in BRCA1 or BRCA2 have a greatly increased risk of developing ovarian cancer, but the importance of behavioral factors is less clear. We used a case-only design to compare the magnitude of associations with established reproductive, hormonal, and lifestyle risk factors between BRCA mutation carriers and noncarriers.
methodsWe pooled data from five studies from the Ovarian Cancer Association Consortium including 637 BRCA carriers and 4,289 noncarriers. Covariate-adjusted generalized linear mixed models were used to estimate interaction risk ratios (IRR) and 95% confidence intervals (CI), with BRCA (carrier vs. noncarrier) as the response variable.
resultsIRRs were above 1.0 for known protective factors including ever being pregnant (IRR = 1.29, 95% CI; 1.00-1.67) and ever using the oral contraceptive pill (1.30, 95% CI; 1.07-1.60), suggesting the protective effects of these factors may be reduced in carriers compared with noncarriers. Conversely, the IRRs for risk factors including endometriosis and menopausal hormone therapy were below 1.0, suggesting weaker positive associations among BRCA carriers. In contrast, associations with lifestyle factors including smoking, physical inactivity, body mass index, and aspirin use did not appear to differ by BRCA status.
conclusionsOur results suggest that associations with hormonal and reproductive factors are generally weaker for those with a pathogenic BRCA variant than those without, while associations with modifiable lifestyle factors are similar for carriers and noncarriers. IMPACT: Advice to maintain a healthy weight, be physically active, and refrain from smoking will therefore benefit BRCA carriers as well as noncarriers.
Indexed as
BRCA1 ProteinBRCA2 ProteinOvarian NeoplasmsFemaleHumansMutationPregnancyRisk FactorsSmokingBRCA1 ProteinBRCA2 Protein
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis. · full record | OpenQuestion